12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant price movements. Notable gainers included Tevogen Bio Holdings, MSP Recovery, and TC BioPharm, while 10x Genomics and Trinity Biotech were among the losers.
October 09, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Trinity Biotech's stock fell by 6.98% to $1.6, with a market cap of $15.1 million, indicating a negative after-market session.
The decline in stock price suggests negative sentiment or developments, potentially leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
10x Genomics experienced a significant decline of 25.6% in its stock price, reducing its market cap to $1.8 billion.
The sharp decline suggests negative news or sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
MSP Recovery's stock rose by 9.44% to $0.15, with a market cap of $3.9 million, indicating positive movement in the after-market session.
The upward movement in stock price suggests positive developments or investor sentiment, potentially leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
TC BioPharm shares increased by 7.42% to $5.35, with a market cap of $2.7 million, reflecting positive after-market performance.
The stock's rise indicates positive sentiment or news, suggesting potential for short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Tevogen Bio Holdings saw a significant increase of 31.2% in its stock price during the after-market session, raising its market cap to $58 million.
The substantial price increase suggests positive investor sentiment or news, likely leading to further interest and potential short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100